| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 6.50e-07 | 3 | 174 | 3 | GO:0008332 | |
| GeneOntologyMolecularFunction | MAP kinase activity | 9.34e-06 | 16 | 174 | 4 | GO:0004707 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase p38 binding | 2.22e-05 | 7 | 174 | 3 | GO:0048273 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | NTRK2 POLR2A SRC PTDSS1 MAP3K20 TSSK2 SRMS ACVR2A CASK FCSK PARP4 MAPK14 MAPK12 MTOR ULK4 LTBP1 EIF2AK1 MAPK13 GDPGP1 MAP2K7 MAP3K19 | 7.04e-05 | 938 | 174 | 21 | GO:0016772 |
| GeneOntologyMolecularFunction | protein kinase activity | NTRK2 SRC MAP3K20 TSSK2 SRMS ACVR2A CASK MAPK14 MAPK12 MTOR ULK4 LTBP1 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 7.47e-05 | 600 | 174 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | glucosamine-6-phosphate deaminase activity | 7.55e-05 | 2 | 174 | 2 | GO:0004342 | |
| GeneOntologyMolecularFunction | G-rich single-stranded DNA binding | 7.55e-05 | 2 | 174 | 2 | GO:1990955 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MAP3K20 TSSK2 ACVR2A CASK MAPK14 MAPK12 MTOR ULK4 LTBP1 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 1.52e-04 | 446 | 174 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | NTRK2 SRC MAP3K20 TSSK2 SRMS ACVR2A CASK FCSK MAPK14 MAPK12 MTOR ULK4 LTBP1 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 1.60e-04 | 709 | 174 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.21e-04 | 14 | 174 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | MAP3K20 TSSK2 CASK MAPK14 MAPK12 MTOR ULK4 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 3.54e-04 | 363 | 174 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | kinase activity | NTRK2 SRC MAP3K20 TSSK2 SRMS ACVR2A CASK FCSK MAPK14 MAPK12 MTOR ULK4 LTBP1 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 3.83e-04 | 764 | 174 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | calcium ion binding | SYT3 CDHR3 LCP1 LRP1B SVEP1 GSN FBLN2 FBN1 DST VCAN JAG1 USP32 MACF1 LTBP1 TNNC1 VWA2 | 8.80e-04 | 749 | 174 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | microfibril binding | 1.11e-03 | 6 | 174 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 1.17e-03 | 53 | 174 | 4 | GO:0016879 | |
| GeneOntologyBiologicalProcess | glutamine family amino acid metabolic process | 4.55e-06 | 80 | 171 | 7 | GO:0009064 | |
| GeneOntologyBiologicalProcess | p38MAPK cascade | 1.95e-05 | 67 | 171 | 6 | GO:0038066 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | SRC VIT TECTA SVEP1 CASK JUP KANK1 FBLN2 CSPG5 JAG1 MACF1 VWA2 VCL | 3.95e-05 | 410 | 171 | 13 | GO:0031589 |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 4.33e-05 | 77 | 171 | 6 | GO:0007004 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 5.34e-05 | 254 | 171 | 10 | GO:0010810 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 6.62e-05 | 83 | 171 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | glucosamine catabolic process | 6.83e-05 | 2 | 171 | 2 | GO:0006043 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 7.85e-05 | 266 | 171 | 10 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell differentiation | 9.21e-05 | 29 | 171 | 4 | GO:0090335 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 1.04e-04 | 90 | 171 | 6 | GO:0010833 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 1.40e-04 | 60 | 171 | 5 | GO:0032210 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 1.51e-04 | 288 | 171 | 10 | GO:0045637 | |
| GeneOntologyBiologicalProcess | stress-activated MAPK cascade | 1.51e-04 | 61 | 171 | 5 | GO:0051403 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.76e-04 | 63 | 171 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | N-acetylglucosamine catabolic process | 2.04e-04 | 3 | 171 | 2 | GO:0006046 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | KNTC1 POT1 APC2 SRC APC GSN CCNB1 KANK1 MTOR FBXO43 ARAP1 SMG6 | 2.12e-04 | 421 | 171 | 12 | GO:0010639 |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 2.31e-04 | 104 | 171 | 6 | GO:0042490 | |
| GeneOntologyBiologicalProcess | positive regulation of erythrocyte differentiation | 2.43e-04 | 37 | 171 | 4 | GO:0045648 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 2.69e-04 | 107 | 171 | 6 | GO:2001251 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 2.70e-04 | 69 | 171 | 5 | GO:1904356 | |
| GeneOntologyBiologicalProcess | stress-activated protein kinase signaling cascade | 2.70e-04 | 69 | 171 | 5 | GO:0031098 | |
| GeneOntologyBiologicalProcess | action potential | 2.80e-04 | 201 | 171 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.92e-04 | 153 | 171 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | KNTC1 ABI3 DSTN SYT3 TCP1 POT1 APC2 SRC MAP3K20 APC LCP1 GSN CCNB1 KANK1 AKAP9 CSF3 MTOR SYNE2 CHFR FBXO43 EIF2AK1 MAP2K7 ARAP1 SMG6 | 3.03e-04 | 1342 | 171 | 24 | GO:0033043 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 3.44e-04 | 112 | 171 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of podosome assembly | 3.50e-04 | 17 | 171 | 3 | GO:0071801 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 3.53e-04 | 208 | 171 | 8 | GO:0170033 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 3.64e-04 | 41 | 171 | 4 | GO:0086091 | |
| GeneOntologyBiologicalProcess | cellular response to methionine | 4.06e-04 | 4 | 171 | 2 | GO:0061431 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 4.06e-04 | 4 | 171 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | epithelial cell-cell adhesion | 4.17e-04 | 18 | 171 | 3 | GO:0090136 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 4.29e-04 | 163 | 171 | 7 | GO:0007093 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 4.35e-04 | 270 | 171 | 9 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 4.68e-04 | 217 | 171 | 8 | GO:0000075 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 4.78e-04 | 44 | 171 | 4 | GO:0006958 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 4.96e-04 | 167 | 171 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | GAPVD1 NTRK2 POT1 APC2 ARHGAP22 MTOR SGSM2 RIPOR1 RIC1 ARAP1 | 5.02e-04 | 335 | 171 | 10 | GO:0043087 |
| GeneOntologyBiologicalProcess | regulation of calcium ion-dependent exocytosis | 5.21e-04 | 45 | 171 | 4 | GO:0017158 | |
| GeneOntologyCellularComponent | supramolecular fiber | KNTC1 COL6A3 DNAH3 KRT78 TCP1 APC2 SRC EML6 APC LCP1 GSN PARP4 JUP FBN1 DST SYNE2 MACF1 LTBP1 TPPP3 TNNC1 CTPS1 ATP2B4 MTUS2 VCL INVS | 1.42e-05 | 1179 | 173 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KNTC1 COL6A3 DNAH3 KRT78 TCP1 APC2 SRC EML6 APC LCP1 GSN PARP4 JUP FBN1 DST SYNE2 MACF1 LTBP1 TPPP3 TNNC1 CTPS1 ATP2B4 MTUS2 VCL INVS | 1.59e-05 | 1187 | 173 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | catenin complex | 1.36e-04 | 32 | 173 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 1.58e-04 | 185 | 173 | 8 | GO:0101002 | |
| GeneOntologyCellularComponent | podocyte foot | 2.03e-04 | 3 | 173 | 2 | GO:0098846 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.48e-04 | 17 | 173 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | podosome | 3.61e-04 | 41 | 173 | 4 | GO:0002102 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KNTC1 DNAH3 KRT78 TCP1 APC2 SRC EML6 APC LCP1 GSN PARP4 JUP DST MACF1 TPPP3 MTUS2 VCL INVS | 4.89e-04 | 899 | 173 | 18 | GO:0099513 |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 5.88e-04 | 124 | 173 | 6 | GO:1904813 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 9.90e-04 | 137 | 173 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | actin cytoskeleton | KNTC1 DSTN ACTR10 APC2 SRC LCP1 GSN CASK JUP DST MACF1 TNNC1 VCL | 1.05e-03 | 576 | 173 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | presynaptic active zone | 1.15e-03 | 141 | 173 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | extracellular matrix | LRRC3C COL6A3 VIT TECTA SVEP1 CASK FBLN2 FBN1 DST VCAN AHSG LTBP1 VWA2 OTOG | 1.15e-03 | 656 | 173 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LRRC3C COL6A3 VIT TECTA SVEP1 CASK FBLN2 FBN1 DST VCAN AHSG LTBP1 VWA2 OTOG | 1.19e-03 | 658 | 173 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | glutamatergic synapse | DSTN NTRK2 UBE3B SRC APC FAAH ARHGAP22 MAPK14 AKAP9 MTOR CSPG5 KCNMA1 CTBP1 CTBP2 CACNA1H ATP2B4 | 1.27e-03 | 817 | 173 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | pericentriolar material | 1.57e-03 | 28 | 173 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | microtubule | KNTC1 DNAH3 TCP1 APC2 EML6 APC PARP4 DST MACF1 TPPP3 MTUS2 INVS | 1.66e-03 | 533 | 173 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | sodium channel complex | 1.74e-03 | 29 | 173 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.85e-03 | 8 | 173 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | BBSome | 1.85e-03 | 8 | 173 | 2 | GO:0034464 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.87e-03 | 210 | 173 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | ruffle membrane | 2.06e-03 | 108 | 173 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | other organism part | 2.36e-03 | 9 | 173 | 2 | GO:0044217 | |
| Domain | VDCC_T_a1 | 7.95e-07 | 3 | 174 | 3 | IPR005445 | |
| Domain | MAPK_p38 | 3.16e-06 | 4 | 174 | 3 | IPR008352 | |
| Domain | Kinase-like_dom | NTRK2 SRC MAP3K20 TSSK2 SRMS ACVR2A CASK MAPK14 DST MAPK12 MTOR ULK4 MACF1 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 1.31e-05 | 542 | 174 | 17 | IPR011009 |
| Domain | EGF_CA | 1.89e-05 | 122 | 174 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.12e-05 | 124 | 174 | 8 | IPR001881 | |
| Domain | EGF-like_dom | TECTA LRP1B SVEP1 FBLN2 FBN1 CSPG5 VCAN JAG1 LTBP1 VWA2 OTOG | 2.25e-05 | 249 | 174 | 11 | IPR000742 |
| Domain | ANATO | 2.71e-05 | 7 | 174 | 3 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 2.71e-05 | 7 | 174 | 3 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.71e-05 | 7 | 174 | 3 | PS01177 | |
| Domain | ANATO | 2.71e-05 | 7 | 174 | 3 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 2.71e-05 | 7 | 174 | 3 | IPR000020 | |
| Domain | EGF_Ca-bd_CS | 3.43e-05 | 97 | 174 | 7 | IPR018097 | |
| Domain | EGF_CA | 3.91e-05 | 99 | 174 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.17e-05 | 100 | 174 | 7 | PS00010 | |
| Domain | ACTININ_2 | 5.61e-05 | 23 | 174 | 4 | PS00020 | |
| Domain | ACTININ_1 | 5.61e-05 | 23 | 174 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.61e-05 | 23 | 174 | 4 | IPR001589 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.06e-05 | 106 | 174 | 7 | IPR000152 | |
| Domain | - | 6.58e-05 | 74 | 174 | 6 | 3.40.50.410 | |
| Domain | EGF | 7.32e-05 | 235 | 174 | 10 | SM00181 | |
| Domain | EGF_3 | 7.32e-05 | 235 | 174 | 10 | PS50026 | |
| Domain | APC_r | 8.63e-05 | 2 | 174 | 2 | PF05923 | |
| Domain | SAMP | 8.63e-05 | 2 | 174 | 2 | PF05924 | |
| Domain | Glucosamine6P_isomerase_CS | 8.63e-05 | 2 | 174 | 2 | IPR018321 | |
| Domain | Glucosamine6P_isomerase | 8.63e-05 | 2 | 174 | 2 | IPR004547 | |
| Domain | GLC_GALNAC_ISOMERASE | 8.63e-05 | 2 | 174 | 2 | PS01161 | |
| Domain | APC_dom | 8.63e-05 | 2 | 174 | 2 | IPR026831 | |
| Domain | APC_N | 8.63e-05 | 2 | 174 | 2 | IPR032038 | |
| Domain | APC_basic_dom | 8.63e-05 | 2 | 174 | 2 | IPR009234 | |
| Domain | Apc_fam | 8.63e-05 | 2 | 174 | 2 | IPR026818 | |
| Domain | APC_rpt | 8.63e-05 | 2 | 174 | 2 | IPR009223 | |
| Domain | SAMP | 8.63e-05 | 2 | 174 | 2 | IPR009224 | |
| Domain | APC_basic | 8.63e-05 | 2 | 174 | 2 | PF05956 | |
| Domain | APC_N_CC | 8.63e-05 | 2 | 174 | 2 | PF16689 | |
| Domain | VDCCAlpha1 | 9.09e-05 | 10 | 174 | 3 | IPR002077 | |
| Domain | cEGF | 9.27e-05 | 26 | 174 | 4 | PF12662 | |
| Domain | cEGF | 9.27e-05 | 26 | 174 | 4 | IPR026823 | |
| Domain | PROTEIN_KINASE_ATP | NTRK2 SRC MAP3K20 TSSK2 SRMS ACVR2A CASK MAPK14 MAPK12 ULK4 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 1.05e-04 | 459 | 174 | 14 | PS00107 |
| Domain | EGF_CA | 1.52e-04 | 86 | 174 | 6 | PF07645 | |
| Domain | MAPK | 1.64e-04 | 12 | 174 | 3 | PS01351 | |
| Domain | MAP_kinase_CS | 1.64e-04 | 12 | 174 | 3 | IPR003527 | |
| Domain | VWA | 1.72e-04 | 56 | 174 | 5 | PF00092 | |
| Domain | EGF | 1.80e-04 | 126 | 174 | 7 | PF00008 | |
| Domain | Prot_kinase_dom | NTRK2 SRC MAP3K20 TSSK2 SRMS ACVR2A CASK MAPK14 MAPK12 ULK4 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 2.03e-04 | 489 | 174 | 14 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | NTRK2 SRC MAP3K20 TSSK2 SRMS ACVR2A CASK MAPK14 MAPK12 ULK4 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 2.20e-04 | 493 | 174 | 14 | PS50011 |
| Domain | - | 2.42e-04 | 222 | 174 | 9 | 1.25.10.10 | |
| Domain | Serum_albumin/AFP/Afamin | 2.57e-04 | 3 | 174 | 2 | IPR021177 | |
| Domain | PIN_domain-like | 2.68e-04 | 14 | 174 | 3 | IPR029060 | |
| Domain | VWF_A | 3.28e-04 | 99 | 174 | 6 | IPR002035 | |
| Domain | ALBUMIN | 5.11e-04 | 4 | 174 | 2 | SM00103 | |
| Domain | Serum_albumin_N | 5.11e-04 | 4 | 174 | 2 | IPR014760 | |
| Domain | 2-Hacid_dh_C | 5.11e-04 | 4 | 174 | 2 | PF02826 | |
| Domain | Serum_albumin_CS | 5.11e-04 | 4 | 174 | 2 | IPR020857 | |
| Domain | ALBUMIN_2 | 5.11e-04 | 4 | 174 | 2 | PS51438 | |
| Domain | 2-Hacid_dh | 5.11e-04 | 4 | 174 | 2 | PF00389 | |
| Domain | D_2_HYDROXYACID_DH_1 | 5.11e-04 | 4 | 174 | 2 | PS00065 | |
| Domain | D_2_HYDROXYACID_DH_2 | 5.11e-04 | 4 | 174 | 2 | PS00670 | |
| Domain | D_2_HYDROXYACID_DH_3 | 5.11e-04 | 4 | 174 | 2 | PS00671 | |
| Domain | ALBUMIN_1 | 5.11e-04 | 4 | 174 | 2 | PS00212 | |
| Domain | PIN_4 | 5.11e-04 | 4 | 174 | 2 | PF13638 | |
| Domain | Glc/Gal-6P_isomerase | 5.11e-04 | 4 | 174 | 2 | IPR006148 | |
| Domain | D-isomer_2_OHA_DH_cat_dom | 5.11e-04 | 4 | 174 | 2 | IPR006139 | |
| Domain | Serum_albumin | 5.11e-04 | 4 | 174 | 2 | PF00273 | |
| Domain | D-isomer_DH_CS | 5.11e-04 | 4 | 174 | 2 | IPR029753 | |
| Domain | Glucosamine_iso | 5.11e-04 | 4 | 174 | 2 | PF01182 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 5.85e-04 | 18 | 174 | 3 | IPR008930 | |
| Domain | PROTEIN_KINASE_ST | MAP3K20 TSSK2 ACVR2A CASK MAPK14 MAPK12 ULK4 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 6.01e-04 | 362 | 174 | 11 | PS00108 |
| Domain | EGF_1 | 6.62e-04 | 255 | 174 | 9 | PS00022 | |
| Domain | VWC_out | 6.90e-04 | 19 | 174 | 3 | SM00215 | |
| Domain | EGF-like_CS | 7.81e-04 | 261 | 174 | 9 | IPR013032 | |
| Domain | Anaphylatoxin_comp_syst | 8.47e-04 | 5 | 174 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 8.47e-04 | 5 | 174 | 2 | IPR001840 | |
| Domain | Serum_albumin-like | 8.47e-04 | 5 | 174 | 2 | IPR020858 | |
| Domain | MAPK_JNK | 8.47e-04 | 5 | 174 | 2 | IPR008351 | |
| Domain | D-isomer_DH_NAD-bd | 8.47e-04 | 5 | 174 | 2 | IPR006140 | |
| Domain | EGF_2 | 8.70e-04 | 265 | 174 | 9 | PS01186 | |
| Domain | ARM-like | 9.92e-04 | 270 | 174 | 9 | IPR011989 | |
| Domain | VWFA | 1.01e-03 | 82 | 174 | 5 | PS50234 | |
| Domain | VWA | 1.13e-03 | 84 | 174 | 5 | SM00327 | |
| Domain | Spectrin | 1.23e-03 | 23 | 174 | 3 | PF00435 | |
| Domain | - | 1.26e-03 | 6 | 174 | 2 | 3.90.1290.10 | |
| Domain | PIN_dom | 1.26e-03 | 6 | 174 | 2 | IPR002716 | |
| Domain | GAR | 1.26e-03 | 6 | 174 | 2 | PS51460 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 1.26e-03 | 6 | 174 | 2 | IPR016332 | |
| Domain | GAS2 | 1.26e-03 | 6 | 174 | 2 | PF02187 | |
| Domain | PINc | 1.26e-03 | 6 | 174 | 2 | SM00670 | |
| Domain | - | 1.26e-03 | 6 | 174 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.26e-03 | 6 | 174 | 2 | IPR003108 | |
| Domain | ALB/AFP/VDB | 1.26e-03 | 6 | 174 | 2 | IPR000264 | |
| Domain | GAS2 | 1.26e-03 | 6 | 174 | 2 | SM00243 | |
| Domain | Ank | 1.36e-03 | 228 | 174 | 8 | PF00023 | |
| Domain | - | 1.39e-03 | 24 | 174 | 3 | 3.40.20.10 | |
| Domain | ADF-H/Gelsolin-like_dom | 1.39e-03 | 24 | 174 | 3 | IPR029006 | |
| Domain | TB | 1.76e-03 | 7 | 174 | 2 | PF00683 | |
| Domain | Plectin | 1.76e-03 | 7 | 174 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.76e-03 | 7 | 174 | 2 | IPR001101 | |
| Domain | PLEC | 1.76e-03 | 7 | 174 | 2 | SM00250 | |
| Domain | Ser/Thr_kinase_AS | MAP3K20 TSSK2 ACVR2A CASK MAPK14 MAPK12 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 1.94e-03 | 357 | 174 | 10 | IPR008271 |
| Domain | S_TKc | MAP3K20 TSSK2 ACVR2A CASK MAPK14 MAPK12 EIF2AK1 MAPK13 MAP2K7 MAP3K19 | 2.02e-03 | 359 | 174 | 10 | SM00220 |
| Domain | HEAT | 2.09e-03 | 58 | 174 | 4 | IPR000357 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 4.22e-06 | 13 | 127 | 4 | M1441 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 1.40e-05 | 6 | 127 | 3 | M47766 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 2.72e-05 | 20 | 127 | 4 | M12256 | |
| Pathway | WP_MAPK_SIGNALING | NTRK2 MAP3K20 MAPK14 MAPK12 CACNA1I CACNA1H CACNA1G DUSP10 MAPK13 MAP2K7 | 7.64e-05 | 246 | 127 | 10 | M39597 |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 8.05e-05 | 26 | 127 | 4 | M47565 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.04e-04 | 120 | 127 | 7 | MM14982 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 1.09e-04 | 28 | 127 | 4 | M39572 | |
| Pathway | PID_P38_GAMMA_DELTA_PATHWAY | 1.12e-04 | 11 | 127 | 3 | M209 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 1.25e-04 | 29 | 127 | 4 | M39676 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | NTRK2 MAP3K20 MAPK14 MAPK12 CACNA1I CACNA1H CACNA1G DUSP10 MAPK13 MAP2K7 | 1.50e-04 | 267 | 127 | 10 | M10792 |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 2.36e-04 | 34 | 127 | 4 | M13881 | |
| Pathway | SIG_CD40PATHWAYMAP | 2.36e-04 | 34 | 127 | 4 | M12705 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.54e-04 | 63 | 127 | 5 | M11187 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | NTRK2 POLR2A SRC APC CCNB1 KANK1 AKAP9 MTOR JAG1 CTBP1 CTBP2 DUSP10 VCL | 2.82e-04 | 464 | 127 | 13 | M27547 |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 2.96e-04 | 36 | 127 | 4 | M39908 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 3.33e-04 | 103 | 127 | 6 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 3.88e-04 | 106 | 127 | 6 | M27077 | |
| Pathway | PID_CDC42_PATHWAY | 4.16e-04 | 70 | 127 | 5 | M81 | |
| Pubmed | TNPO1 GAPVD1 NSD2 MTHFD1L POLR2A LCP1 ANKHD1 DDX27 DIS3 DST FAM120A GTF3C1 UBR5 MTOR ASNS SYNE2 ANKRD17 HELZ MACF1 CLUH VCL | 2.70e-11 | 653 | 178 | 21 | 22586326 | |
| Pubmed | DSTN SYT3 NTRK2 APC2 SRC ZBTB22 APC GSN CASK DST FAM120A AKAP9 UBR5 MTOR SYNE2 KCNMA1 ANKRD17 MACF1 PRMT1 CTBP1 CTBP2 TNS1 ATP2B4 SMG6 | 1.78e-10 | 963 | 178 | 24 | 28671696 | |
| Pubmed | MCM8 TTC28 TCP1 UBE3B APC EXOC3 ANKHD1 DIS3 PARP4 DST FAM120A TRMT2A GTF3C1 NEMF ANKRD17 HELZ C4A C4B CLSPN RIC1 | 1.79e-10 | 650 | 178 | 20 | 38777146 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TNPO1 GAPVD1 MTHFD1L LCP1 ANKHD1 DDX27 DIS3 GSN CCNB1 CASK MAPK14 FAM120A GTF3C1 UBR5 MTOR ASNS ANKRD17 HELZ PRMT1 DUSP10 GFM1 CLUH VCL | 1.24e-09 | 974 | 178 | 23 | 28675297 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | B3GNTL1 MCM8 NSD2 SRC PTDSS1 TECTA CDC14B CASZ1 CASK ANKRD44 FAM120A GTF3C1 SGSM2 TTC12 NEMF KCNMA1 ZFHX2 ANKRD17 MACF1 RIPOR1 CTBP1 CTBP2 CACNA1H OSTF1 RIC1 ARAP1 INVS SMG6 | 2.74e-09 | 1489 | 178 | 28 | 28611215 |
| Pubmed | KNTC1 GAPVD1 TTC28 POLR2A APC FASTKD5 KANK1 TBC1D31 FAM120A BBS7 HELZ PRR14L CTPS1 CLSPN GFM1 CLUH ITPRIPL1 VCL TGS1 | 8.60e-09 | 733 | 178 | 19 | 34672954 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | TNPO1 GAPVD1 MTHFD1L LCP1 DIS3 GSN JUP ASNS SEC24B PRMT1 CTBP1 CTBP2 CTPS1 GFM1 CLUH VCL GOT2 | 1.78e-08 | 607 | 178 | 17 | 39147351 |
| Pubmed | GAPVD1 GNPDA1 DSTN MTHFD1L POLR2A ANKHD1 DIS3 LIG1 FAM120A GTF3C1 UBR5 ASNS ANKRD17 CTBP2 CTPS1 GFM1 | 1.89e-08 | 534 | 178 | 16 | 35032548 | |
| Pubmed | THSD7A TTC28 DIS3 TTC7A DST UBR5 SYNE2 MACF1 CACNA1G ARAP1 SMG6 | 2.62e-08 | 225 | 178 | 11 | 12168954 | |
| Pubmed | KNTC1 GNPDA1 THSD7A PTDSS1 ANKRD6 CASZ1 RUFY2 TRIM66 PARP4 RIMKLB FAM120A SACS MACF1 EIF2AK1 RIC1 | 4.37e-08 | 493 | 178 | 15 | 15368895 | |
| Pubmed | TCP1 NSD2 POLR2A FBXL14 EXOC3 CDC14B DDX27 CASK ARHGAP5 MAPK14 TBC1D31 AKAP9 CSPG5 SYNE2 SEC24B KCNMA1 HELZ LTBP1 DUSP10 TNS1 ATP2B4 | 1.13e-07 | 1049 | 178 | 21 | 27880917 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DSTN TCP1 MTHFD1L POLR2A MAP3K20 EXOC3 ANKHD1 DDX27 DIS3 JUP DST FAM120A GTF3C1 UBR5 ASNS SEC24B ANKRD17 MACF1 PRMT1 CTBP2 PRR14L CTPS1 VCL GOT2 | 1.24e-07 | 1353 | 178 | 24 | 29467282 |
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 1.32e-07 | 3 | 178 | 3 | 23488970 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 1.32e-07 | 3 | 178 | 3 | 11230107 | |
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 1.32e-07 | 3 | 178 | 3 | 28972185 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 11897840 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 1.32e-07 | 3 | 178 | 3 | 18591418 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 28846697 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 21665989 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 33547341 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 11927664 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 18559936 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TNPO1 KNTC1 GAPVD1 TCP1 NSD2 MTHFD1L POLR2A FASTKD5 ANKHD1 DDX27 DIS3 JUP FAM120A GTF3C1 MTOR ASNS NEMF PRMT1 CTBP2 CTPS1 GFM1 CLUH VCL GOT2 | 3.17e-07 | 1425 | 178 | 24 | 30948266 |
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 3.18e-07 | 12 | 178 | 4 | 9297626 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TNPO1 GAPVD1 ACTR10 UBE3B PTDSS1 EXOC3 BBS9 DIS3 GSN MTOR BBS7 SEC24B HELZ PRMT1 RIPOR1 CTBP1 CTBP2 MINDY4 EIF2AK1 CLUH VCL INVS IPO11 | 3.22e-07 | 1321 | 178 | 23 | 27173435 |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | TNPO1 GAPVD1 MTHFD1L ACTR10 CDC14B CCNB1 MAPK14 UBR5 BBS7 AFM HELZ PRMT1 CTBP1 CTBP2 DUSP10 GFM1 MRPL24 TNS1 CLUH | 3.55e-07 | 931 | 178 | 19 | 27432908 |
| Pubmed | DSTN THSD7A SVEP1 CASK ARHGAP5 JUP DCUN1D1 KANK1 DST UBR5 MACF1 CTBP2 MAPK13 VCL INVS | 4.46e-07 | 591 | 178 | 15 | 15231748 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TNPO1 KNTC1 GAPVD1 GNPDA1 TCP1 ACTR10 POLR2A PGGT1B DIS3 LIG1 JUP DCUN1D1 MAPK14 MTOR GNPDA2 ASNS MACF1 PRMT1 RIPOR1 CTBP2 CTPS1 CLUH VCL IPO11 | 4.61e-07 | 1455 | 178 | 24 | 22863883 |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 20610565 | ||
| Pubmed | Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis. | 5.25e-07 | 4 | 178 | 3 | 18177852 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 26795633 | ||
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 5.25e-07 | 4 | 178 | 3 | 28165634 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 10066767 | ||
| Pubmed | TNPO1 GAPVD1 ETS1 APC ACVR2A ANKRD6 ANKHD1 PGGT1B DIS3 ARHGAP5 JUP DCUN1D1 TBC1D31 ALDH1L2 UBP1 VCAN ANKRD17 MACF1 TNS1 TGS1 | 8.30e-07 | 1084 | 178 | 20 | 11544199 | |
| Pubmed | 9.29e-07 | 146 | 178 | 8 | 27068509 | ||
| Pubmed | 9.37e-07 | 101 | 178 | 7 | 9872452 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ABI3 THSD7A SYT3 TCP1 POLR2A APC CASK ARHGAP5 FAM120A UBP1 NEMF KCNMA1 MTUS2 | 1.17e-06 | 475 | 178 | 13 | 31040226 |
| Pubmed | KRT78 DSTN SYT3 TCP1 PTDSS1 APC GSN CASK ARHGAP5 JUP DST FAM120A SACS VCAN MACF1 CTBP1 C4A C4B TNS1 ATP2B4 MTUS2 VCL GOT2 | 1.27e-06 | 1431 | 178 | 23 | 37142655 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 15632108 | ||
| Pubmed | MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation. | 1.31e-06 | 5 | 178 | 3 | 35971771 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 17304211 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TNPO1 GAPVD1 KRT78 TCP1 POLR2A SRC EXOC3 DDX27 GSN JUP DST GTF3C1 SACS UBR5 BBS7 SYNE2 MACF1 PRMT1 GOT2 | 1.46e-06 | 1024 | 178 | 19 | 24711643 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | GAPVD1 MTHFD1L POLR2A EXOC3 LCP1 GTF3C1 IGHMBP2 USP32 C4A C4B CTPS1 RIC1 IPO11 | 1.93e-06 | 497 | 178 | 13 | 36774506 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | GNPDA1 POLR2A DIS3 CASK JUP DST SACS VCAN ASNS SYNE2 MACF1 CTBP1 CTPS1 | 1.97e-06 | 498 | 178 | 13 | 36634849 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GAPVD1 KRT78 TTC28 MAP3K20 TSSK2 APC JUP DST AKAP9 MTOR SYNE2 SEC24B ANKRD17 HELZ MACF1 MAP2K7 OTOG | 2.37e-06 | 861 | 178 | 17 | 36931259 |
| Pubmed | Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice. | 2.61e-06 | 6 | 178 | 3 | 27856911 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 14680475 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 19349279 | ||
| Pubmed | TTC28 APC2 APC ANKRD6 LRP1B DDX27 CASK RUFY2 TRIM66 ARHGAP5 FBN1 DST FAM120A SACS SGSM2 NEMF USP32 MACF1 CTBP1 EIF2AK1 MTUS2 | 2.95e-06 | 1285 | 178 | 21 | 35914814 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | COL6A3 TCP1 TAF1A ETS1 CDC14B DIS3 GSN DST CACNA1G TNS1 RAD54L | 3.03e-06 | 363 | 178 | 11 | 14691545 |
| Pubmed | 3.52e-06 | 298 | 178 | 10 | 30737378 | ||
| Pubmed | 3.71e-06 | 21 | 178 | 4 | 8138038 | ||
| Pubmed | NTRK2 SRC ETS1 APC CCNB1 JUP MAPK14 MAPK12 MTOR MAPK13 MAP2K7 | 3.73e-06 | 371 | 178 | 11 | 25241761 | |
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 15729360 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | GAPVD1 SRC MAP3K20 FASTKD5 ACVR2A ANKRD36C CCNB1 MAPK14 DST TRMT2A AKAP9 GTF3C1 CTBP2 OSTF1 CLSPN MAPK13 TNS1 | 4.92e-06 | 910 | 178 | 17 | 36736316 |
| Pubmed | MCM8 TTC28 NSD2 POLR2A FASTKD5 ANKHD1 PLEKHN1 ADH4 TTC7A FCSK TRIM66 FAM120A TRMT2A UBR5 ANKRD17 HELZ MACF1 CLSPN MAP2K7 | 5.07e-06 | 1116 | 178 | 19 | 31753913 | |
| Pubmed | TNPO1 GAPVD1 DSTN TCP1 POLR2A APC DDX27 DIS3 JUP KANK1 FAM120A AKAP9 IGHMBP2 ASNS SEC24B NEMF ANKRD17 CTBP1 CTBP2 VCL | 6.81e-06 | 1247 | 178 | 20 | 27684187 | |
| Pubmed | Regulation of a mitogen-activated protein kinase kinase kinase, MLTK by PKN. | 7.24e-06 | 8 | 178 | 3 | 12761180 | |
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 28330839 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 7.24e-06 | 8 | 178 | 3 | 12761855 | |
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 34478646 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 14670299 | ||
| Pubmed | SRC APC DDX27 JUP MAPK14 DST ANKRD17 HELZ MACF1 C4A DUSP10 TNS1 | 8.64e-06 | 486 | 178 | 12 | 20936779 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GAPVD1 TTC28 TCP1 MTHFD1L ACTR10 APC LCP1 LRP1B DDX27 ARHGAP5 TBC1D31 FAM120A UBR5 SEC24B MINDY4 VCL | 9.00e-06 | 853 | 178 | 16 | 28718761 |
| Pubmed | Nerve growth factor signaling, neuroprotection, and neural repair. | 9.08e-06 | 26 | 178 | 4 | 11520933 | |
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 16382099 | ||
| Pubmed | GAPVD1 TTC28 APC ANKHD1 JUP DST GTF3C1 UBR5 ANKRD17 CTBP1 CTBP2 | 1.15e-05 | 418 | 178 | 11 | 34709266 | |
| Pubmed | GAPVD1 TTC28 TCP1 SRC APC BTBD3 CASK ANKRD46 LIG1 DST UBR5 SEC24B AHSG CTBP1 CLSPN | 1.24e-05 | 777 | 178 | 15 | 35844135 | |
| Pubmed | 1.32e-05 | 209 | 178 | 8 | 36779422 | ||
| Pubmed | MTHFD1L ACTR10 POLR2A EXOC3 FASTKD5 GTF3C1 UBR5 ALDH1L2 OSTF1 GFM1 MRPL24 CLUH | 1.54e-05 | 515 | 178 | 12 | 31617661 | |
| Pubmed | 1.54e-05 | 10 | 178 | 3 | 30429287 | ||
| Pubmed | 1.54e-05 | 10 | 178 | 3 | 23001180 | ||
| Pubmed | 1.54e-05 | 10 | 178 | 3 | 24778262 | ||
| Pubmed | 1.62e-05 | 215 | 178 | 8 | 35973513 | ||
| Pubmed | 1.64e-05 | 30 | 178 | 4 | 32867711 | ||
| Pubmed | TNPO1 KNTC1 DSTN TCP1 MTHFD1L FASTKD5 DDX27 DIS3 GSN CCNB1 DST FAM120A GTF3C1 UBR5 MTOR ASNS SYNE2 PRMT1 CTBP1 CTPS1 IPO11 | 1.66e-05 | 1440 | 178 | 21 | 30833792 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.74e-05 | 358 | 178 | 10 | 32460013 | |
| Pubmed | TNPO1 GAPVD1 TTC28 TCP1 APC EXOC3 JUP DST SEC24B ANKRD17 MACF1 PRMT1 CTPS1 VCL | 1.87e-05 | 708 | 178 | 14 | 39231216 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | SRC MAP3K20 RUFY2 LIG1 FBN1 MAPK14 TRMT2A GTF3C1 MTOR SYNE2 PRMT1 RIPOR1 CTBP1 OSTF1 DUSP10 TNS1 GOT2 ARAP1 | 2.06e-05 | 1124 | 178 | 18 | 21900206 |
| Pubmed | KNTC1 GAPVD1 TTC28 MAP3K20 APC ANKRD44 DST AKAP9 UBR5 HELZ IPO11 | 2.09e-05 | 446 | 178 | 11 | 24255178 | |
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 2.11e-05 | 11 | 178 | 3 | 23204401 | |
| Pubmed | 2.11e-05 | 11 | 178 | 3 | 11577104 | ||
| Pubmed | 2.14e-05 | 162 | 178 | 7 | 15174051 | ||
| Pubmed | POLR2A ANO10 ANKRD44 GTF3C1 UBP1 PRMT1 ATP11C CTBP1 CTBP2 C4A MAP2K7 IPO11 | 2.15e-05 | 533 | 178 | 12 | 25544563 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.30e-05 | 370 | 178 | 10 | 22922362 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | TNPO1 KRT78 TAF1A APC ANKHD1 GSN CCNB1 PARP4 FAM120A ANKRD17 HELZ MACF1 CLUH VCL | 2.39e-05 | 724 | 178 | 14 | 36232890 |
| Pubmed | GAPVD1 DSTN TTC28 POLR2A DDX27 CCNB1 JUP DST UBR5 MACF1 LTBP1 ATP2B4 CLUH | 2.58e-05 | 634 | 178 | 13 | 34591612 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 17028196 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 19062096 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 9886271 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 14988077 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.60e-05 | 2 | 178 | 2 | 17645767 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 12207352 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 21622683 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.60e-05 | 2 | 178 | 2 | 27758680 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 12616532 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 25071191 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 11002341 | ||
| Pubmed | C-Terminal Binding Protein is Involved in Promoting to the Carcinogenesis of Human Glioma. | 2.60e-05 | 2 | 178 | 2 | 27699603 | |
| Interaction | SIRT7 interactions | TNPO1 GAPVD1 NSD2 MTHFD1L POLR2A LCP1 ANKHD1 DDX27 DIS3 CCNB1 DST FAM120A GTF3C1 UBR5 MTOR ASNS SYNE2 ANKRD17 HELZ MACF1 CLUH VCL | 4.41e-07 | 744 | 173 | 22 | int:SIRT7 |
| Interaction | PXN interactions | KNTC1 DSTN TTC28 SRC APC PLEKHN1 GSN ARHGAP5 JUP AKAP9 ASNS HELZ MACF1 VCL | 1.21e-06 | 334 | 173 | 14 | int:PXN |
| Interaction | PLEC interactions | DNAH3 KRT78 NSD2 PTDSS1 ETS1 DIS3 ADH6 JUP DST SYNE2 SEC24B FBXO43 MACF1 PRMT1 INVS | 4.79e-06 | 430 | 173 | 15 | int:PLEC |
| Interaction | MAPK10 interactions | 1.66e-05 | 63 | 173 | 6 | int:MAPK10 | |
| Interaction | FBN2 interactions | 1.99e-05 | 65 | 173 | 6 | int:FBN2 | |
| Interaction | BCAR1 interactions | POLR2A SRC DDX27 GSN CASK JUP MAPK14 TRMT2A UBR5 MTOR ALDH1L2 SEC24B OSTF1 MRPL24 TNS1 VCL | 2.52e-05 | 556 | 173 | 16 | int:BCAR1 |
| Interaction | PKP2 interactions | 2.57e-05 | 225 | 173 | 10 | int:PKP2 | |
| Interaction | YWHAE interactions | EGLN3 GAPVD1 TTC28 POT1 SRC MAP3K20 APC CASK ADH4 JUP DCUN1D1 KANK1 MAPK14 DST AKAP9 MTOR ASNS KCNMA1 ANKRD17 MACF1 PRMT1 LTBP1 MINDY4 ATP2B4 VCL OTOG | 2.66e-05 | 1256 | 173 | 26 | int:YWHAE |
| Interaction | DCTN4 interactions | 3.33e-05 | 143 | 173 | 8 | int:DCTN4 | |
| Interaction | EGLN3 interactions | TNPO1 EGLN3 GAPVD1 DSTN TCP1 MTHFD1L POLR2A APC FASTKD5 ANKHD1 PARP4 GTF3C1 UBR5 SEC24B ANKRD17 HELZ PRMT1 CTBP1 CTBP2 PRR14L CTPS1 CLSPN GFM1 CLUH INVS TGS1 | 4.51e-05 | 1296 | 173 | 26 | int:EGLN3 |
| Interaction | NTN5 interactions | 4.87e-05 | 24 | 173 | 4 | int:NTN5 | |
| Interaction | CCDC8 interactions | TNPO1 EGLN3 GAPVD1 KRT78 TCP1 NTRK2 POLR2A SRC EXOC3 JUP MAPK14 DST GTF3C1 SACS UBR5 BBS7 MACF1 | 5.22e-05 | 656 | 173 | 17 | int:CCDC8 |
| Interaction | EFNB1 interactions | TNPO1 KNTC1 SRC ACVR2A ANKRD46 FAM120A SACS TTC12 USP32 IPO11 | 7.37e-05 | 255 | 173 | 10 | int:EFNB1 |
| Interaction | SEC16A interactions | EGLN3 UBE3B ANKHD1 BTBD3 ARHGAP22 TRIM66 FAM120A SEC24B HELZ PRMT1 CTBP1 MAP2K7 VCL | 8.28e-05 | 426 | 173 | 13 | int:SEC16A |
| GeneFamily | Ankyrin repeat domain containing | ANKRD36C ANKRD6 ANKHD1 ANKRD46 ANKRD44 KANK1 ANKRD17 OSTF1 ARAP1 INVS | 3.91e-06 | 242 | 117 | 10 | 403 |
| GeneFamily | Mitogen-activated protein kinases | 7.20e-05 | 13 | 117 | 3 | 651 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 6.12e-04 | 6 | 117 | 2 | 1181 | |
| GeneFamily | Calcium voltage-gated channel subunits | 6.16e-04 | 26 | 117 | 3 | 253 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.13e-03 | 8 | 117 | 2 | 939 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 1.13e-03 | 8 | 117 | 2 | 1122 | |
| GeneFamily | Alcohol dehydrogenases | 1.13e-03 | 8 | 117 | 2 | 397 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.45e-03 | 9 | 117 | 2 | 1234 | |
| GeneFamily | Complement system|Sushi domain containing | 1.61e-03 | 36 | 117 | 3 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 1.75e-03 | 37 | 117 | 3 | 454 | |
| GeneFamily | UPF1 like RNA helicases | 2.20e-03 | 11 | 117 | 2 | 1169 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.70e-03 | 43 | 117 | 3 | 409 | |
| GeneFamily | Armadillo repeat containing|Importins | 5.94e-03 | 18 | 117 | 2 | 596 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.99e-03 | 57 | 117 | 3 | 1179 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | TNPO1 KNTC1 COL6A3 GNPDA1 MCM8 NSD2 MTHFD1L NTRK2 TAF1A POT1 SRC MAP3K20 CCNB1 CASK ANKRD46 RSAD2 FBN1 ABRACL SACS VCAN ASNS KCNMA1 PRMT1 ATP11C CTPS1 GFM1 MRPL24 RAD54L TGS1 | 7.72e-08 | 1407 | 177 | 29 | M14427 |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 9.28e-06 | 200 | 177 | 9 | M9327 | |
| Coexpression | GSE27786_LSK_VS_NKCELL_UP | 9.28e-06 | 200 | 177 | 9 | M4751 | |
| Coexpression | NABA_CORE_MATRISOME | 1.62e-05 | 270 | 177 | 10 | MM17057 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.78e-05 | 120 | 177 | 7 | M42505 | |
| Coexpression | NABA_CORE_MATRISOME | 1.90e-05 | 275 | 177 | 10 | M5884 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GAPVD1 TTC28 APC CASK MAPK14 DST TBC1D31 AKAP9 SACS UBR5 SYNE2 SEC24B ANKRD17 HELZ MACF1 CTBP2 ATP2B4 VCL | 2.14e-05 | 856 | 177 | 18 | M4500 |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 2.29e-05 | 84 | 177 | 6 | M15484 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 2.90e-05 | 289 | 177 | 10 | M41750 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.97e-05 | 300 | 177 | 10 | M8702 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.89e-05 | 191 | 177 | 8 | MM17059 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 5.08e-05 | 192 | 177 | 8 | M42501 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.87e-05 | 196 | 177 | 8 | M3008 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 5.87e-05 | 196 | 177 | 8 | M5381 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP | 6.09e-05 | 197 | 177 | 8 | M9969 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN | 6.53e-05 | 199 | 177 | 8 | M7651 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_UP | 6.66e-05 | 257 | 177 | 9 | MM1231 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 6.77e-05 | 200 | 177 | 8 | M7256 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 6.77e-05 | 200 | 177 | 8 | M6372 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 6.77e-05 | 200 | 177 | 8 | M5915 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 8.94e-05 | 35 | 177 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.00e-04 | 36 | 177 | 4 | MM1212 | |
| Coexpression | HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP | 1.05e-04 | 69 | 177 | 5 | M1319 | |
| Coexpression | HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP | 1.05e-04 | 69 | 177 | 5 | MM1158 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | NTRK2 ETS1 ACVR2A VIT SVEP1 GSN DST ALDH1L2 VCAN JAG1 KCNMA1 TNS1 | 1.08e-04 | 479 | 177 | 12 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | NTRK2 ETS1 ACVR2A VIT SVEP1 GSN DST ALDH1L2 VCAN JAG1 KCNMA1 TNS1 | 1.16e-04 | 483 | 177 | 12 | MM1082 |
| Coexpression | TOMLINS_PROSTATE_CANCER_DN | 1.52e-04 | 40 | 177 | 4 | M11504 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | NSD2 NTRK2 TECTA BBS9 CDC14B MAPK12 CSF3 MTOR USP32 CHFR ZFHX2 CACNA1I C4A CACNA1H C4B TNS1 MAP3K19 | 1.52e-04 | 909 | 177 | 17 | M41018 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | KNTC1 TCP1 NSD2 PTDSS1 CCNB1 LIG1 TBC1D31 UBR5 CTBP1 CTPS1 RAD54L | 1.61e-04 | 426 | 177 | 11 | M9516 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | TNPO1 ACTR10 APC ANKHD1 BTBD3 ARHGAP5 KANK1 SEC24B NEMF ANKRD17 MACF1 | 1.71e-04 | 429 | 177 | 11 | M29 |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 1.84e-04 | 294 | 177 | 9 | M1804 | |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 1.87e-04 | 174 | 177 | 7 | M6881 | |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_DN | 2.18e-04 | 237 | 177 | 8 | M4502 | |
| Coexpression | SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN | 2.29e-04 | 18 | 177 | 3 | M16533 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | COL6A3 LILRA2 ABI3 TTC28 MAP3K20 LCP1 PLEKHN1 SVEP1 GSN ARHGAP22 FBLN2 FBN1 VCAN RIPOR1 OSTF1 LTBP1 DUSP10 CTPS1 CLSPN SMC1B ARAP1 | 2.30e-04 | 1316 | 177 | 21 | MM1052 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.30e-04 | 180 | 177 | 7 | M8239 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | COL6A3 TCP1 ETS1 LCP1 PGGT1B SVEP1 CASK RIMKLB FBLN2 FBN1 VCAN ASNS SYNE2 CACNA1G LTBP1 CTPS1 CLSPN ATP2B4 RAD54L TGS1 | 1.09e-05 | 827 | 170 | 20 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | KNTC1 COL6A3 TCP1 ETS1 CDC14B SVEP1 FBLN2 FBN1 VCAN JAG1 SYNE2 CACNA1H CACNA1G TNNC1 CLSPN MAPK13 TNS1 ATP2B4 TGS1 | 1.34e-05 | 768 | 170 | 19 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.53e-05 | 192 | 170 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | KNTC1 EGLN3 MCM8 TCP1 POT1 C10orf53 CCNB1 RIMKLB CTPS1 CLSPN RAD54L SMC1B | 6.99e-05 | 387 | 170 | 12 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | KNTC1 MCM8 TCP1 POT1 DIS3 RIMKLB UBR5 MTOR CTPS1 CLSPN RAD54L | 8.06e-05 | 333 | 170 | 11 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | KNTC1 EGLN3 MCM8 TCP1 NSD2 POT1 DIS3 CCNB1 LIG1 RIMKLB UBR5 MTOR ASNS HELZ CTPS1 CLSPN RAD54L SMC1B | 1.10e-04 | 822 | 170 | 18 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | KNTC1 EGLN3 MCM8 NSD2 MTHFD1L CDC14B LIG1 PROX2 ASNS CTPS1 CLSPN RAD54L | 1.48e-04 | 419 | 170 | 12 | GSM476664_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | KNTC1 EGLN3 MCM8 TCP1 POT1 DDX27 DIS3 CCNB1 RIMKLB UBR5 ASNS CHFR HELZ CTPS1 CLSPN RAD54L SMC1B | 1.84e-04 | 781 | 170 | 17 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 1.93e-04 | 148 | 170 | 7 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 2.02e-04 | 105 | 170 | 6 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | KNTC1 EGLN3 MCM8 TCP1 POT1 C10orf53 DIS3 CCNB1 RIMKLB UBR5 ASNS CHFR CTPS1 CLSPN MAPK13 RAD54L SMC1B | 2.27e-04 | 795 | 170 | 17 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 2.28e-04 | 152 | 170 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL6A3 SVEP1 ADH4 FBN1 DST AKAP9 GTF3C1 VCAN MACF1 LTBP1 MINDY4 TNS1 | 3.04e-11 | 200 | 177 | 12 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | COL6A3 TTC28 SVEP1 ADH4 FBN1 DST AKAP9 VCAN MACF1 LTBP1 MINDY4 | 5.21e-10 | 200 | 177 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.68e-09 | 196 | 177 | 10 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 8.11e-09 | 200 | 177 | 10 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.70e-08 | 188 | 177 | 9 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.02e-08 | 192 | 177 | 9 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.02e-08 | 192 | 177 | 9 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.39e-08 | 193 | 177 | 9 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.39e-08 | 193 | 177 | 9 | 5f5904cec8b2967154ef2eab3c48f51df53aca4a | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.39e-08 | 193 | 177 | 9 | e27885a9e1a2a3e165c5366d4cfcda05c5454483 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.39e-08 | 193 | 177 | 9 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.16e-08 | 195 | 177 | 9 | 773728703bc8969bff0e1de58fe3e1631add0a0a | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 9.16e-08 | 195 | 177 | 9 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.16e-08 | 195 | 177 | 9 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.16e-08 | 195 | 177 | 9 | bff7685784688425bebd78b0f284a6d4475a9415 | |
| ToppCell | facs-Trachea-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.16e-08 | 195 | 177 | 9 | 0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.09e-07 | 199 | 177 | 9 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 177 | 9 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 177 | 9 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 177 | 9 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-07 | 169 | 177 | 8 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-07 | 172 | 177 | 8 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.91e-07 | 185 | 177 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-07 | 187 | 177 | 8 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-07 | 187 | 177 | 8 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-07 | 188 | 177 | 8 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-07 | 188 | 177 | 8 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-07 | 189 | 177 | 8 | 562f8bf5a7d38afb4a8f2415d617d5f79cfb7e3f | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.29e-07 | 189 | 177 | 8 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-07 | 189 | 177 | 8 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-07 | 189 | 177 | 8 | 270dd4a0fc5260288fe6829837942c78b40ecec4 | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 190 | 177 | 8 | dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 190 | 177 | 8 | 00fd993675faf53adf985b9316a18c8a33242029 | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 190 | 177 | 8 | 0bb06df3d5a50416854370f234718c6cec3d773b | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 190 | 177 | 8 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 190 | 177 | 8 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 190 | 177 | 8 | 008290bb5c79446681dd6bf354336c57ad0d6f13 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 190 | 177 | 8 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.66e-07 | 190 | 177 | 8 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-07 | 190 | 177 | 8 | 8cda09d761c6b504a744959d587c183f94f1beeb | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-06 | 191 | 177 | 8 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.01e-06 | 191 | 177 | 8 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 191 | 177 | 8 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 192 | 177 | 8 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 192 | 177 | 8 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-06 | 192 | 177 | 8 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-06 | 192 | 177 | 8 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-06 | 192 | 177 | 8 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-06 | 192 | 177 | 8 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 192 | 177 | 8 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 192 | 177 | 8 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-06 | 192 | 177 | 8 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-06 | 192 | 177 | 8 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 192 | 177 | 8 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 192 | 177 | 8 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.09e-06 | 193 | 177 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 193 | 177 | 8 | b45cd02081f97904eaea2d013e1fa980505d060b | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 193 | 177 | 8 | 733f557bdc80293b40ccdf560f1675793df932d6 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 193 | 177 | 8 | eb3c46b6fb06dc8708dc3032189b47ed93ee2357 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-06 | 193 | 177 | 8 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.09e-06 | 193 | 177 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.13e-06 | 194 | 177 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.13e-06 | 194 | 177 | 8 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.13e-06 | 194 | 177 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-06 | 194 | 177 | 8 | c9e589fe7df6a9b377654581a2aebb607cbb03b9 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-06 | 195 | 177 | 8 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-06 | 195 | 177 | 8 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-06 | 195 | 177 | 8 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-06 | 195 | 177 | 8 | 0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-06 | 195 | 177 | 8 | aed243418cdb5df4563a7b935c1ecbd744590901 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-06 | 195 | 177 | 8 | 2a6f67875cef140b0e6b8401436719675c6b3665 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 195 | 177 | 8 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-06 | 195 | 177 | 8 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-06 | 195 | 177 | 8 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.17e-06 | 195 | 177 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-06 | 195 | 177 | 8 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-06 | 196 | 177 | 8 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-06 | 196 | 177 | 8 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.27e-06 | 197 | 177 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.27e-06 | 197 | 177 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 177 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-06 | 199 | 177 | 8 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 177 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.37e-06 | 199 | 177 | 8 | 6c0354f57883330c685a8d9d5d3014ace7eca584 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-06 | 199 | 177 | 8 | 9e87b64e16d595701c3beb07aa835afe3330bd10 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-06 | 200 | 177 | 8 | 9dd2eb70c1cc146935f5aff27373dfc65cb8c098 | |
| ToppCell | cellseq2-Mesenchymal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-06 | 200 | 177 | 8 | 6b558cce0d6047c7e85f428adff80c5ca3084ea4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-06 | 200 | 177 | 8 | 5fdca7959134a5c8e06e5d6d14aafe34b963aef2 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-06 | 168 | 177 | 7 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 5.22e-06 | 169 | 177 | 7 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.56e-06 | 175 | 177 | 7 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-06 | 176 | 177 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-06 | 176 | 177 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.61e-06 | 179 | 177 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.61e-06 | 179 | 177 | 7 | ec69e1dd897414033ba5b007aa82655a79adca6c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-06 | 179 | 177 | 7 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 4.70e-07 | 3 | 178 | 3 | CID010679219 | |
| Drug | Ac2-26 | 1.87e-06 | 4 | 178 | 3 | CID000568638 | |
| Drug | NSC-68458 | 1.87e-06 | 4 | 178 | 3 | CID000249771 | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.30e-06 | 195 | 178 | 10 | 7406_UP | |
| Drug | CPI-1189 | 3.40e-06 | 14 | 178 | 4 | CID000151118 | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; PC3; HT_HG-U133A | 3.96e-06 | 199 | 178 | 10 | 4552_DN | |
| Drug | Flunarizine | 4.64e-06 | 5 | 178 | 3 | DB04841 | |
| Drug | Methylcholanthrene | KNTC1 TCP1 SRC VIT DDX27 CCNB1 CASK ADH4 ADH6 ARHGAP22 RSAD2 MAPK12 CSF3 ALDH1L2 JAG1 AHSG C4A C4B CACNA1G LTBP1 EIF2AK1 CLSPN RAD54L | 6.27e-06 | 1034 | 178 | 23 | ctd:D008748 |
| Drug | NSC-364372 | TNPO1 APC2 APC LCP1 CCNB1 KANK1 MAPK14 MAPK12 AKAP9 MTOR CHFR PRMT1 CTBP2 MAPK13 VCL | 6.61e-06 | 484 | 178 | 15 | CID000435143 |
| Drug | 3,4-dihydroquinazoline | 9.24e-06 | 6 | 178 | 3 | CID000583065 | |
| Drug | tolyltriazole | 9.24e-06 | 6 | 178 | 3 | CID000025902 | |
| Drug | SQ22536 | 1.14e-05 | 135 | 178 | 8 | CID000005270 | |
| Drug | LY215840 | 1.61e-05 | 7 | 178 | 3 | CID000132049 | |
| Drug | Cp-38 | 1.61e-05 | 7 | 178 | 3 | CID006918286 | |
| Drug | satratoxin H | 1.61e-05 | 7 | 178 | 3 | CID000434380 | |
| Drug | 2,2',4,6-tetrachlorobiphenyl | 1.61e-05 | 7 | 178 | 3 | CID000044163 | |
| Drug | CID6325568 | 1.61e-05 | 7 | 178 | 3 | CID006325568 | |
| Drug | p-nitrophenyl phosphate | 2.30e-05 | 194 | 178 | 9 | CID000000378 | |
| Drug | AC1L1KMJ | COL6A3 APC2 SRC SRMS LCP1 GSN MAPK14 DST MAPK12 SACS MTOR MACF1 MAPK13 VCL | 2.42e-05 | 476 | 178 | 14 | CID000030956 |
| Drug | Z-D-CH2DCB | 2.56e-05 | 8 | 178 | 3 | CID009911778 | |
| Drug | ML3403 | 2.56e-05 | 8 | 178 | 3 | CID006419739 | |
| Drug | riccardin D | 2.92e-05 | 76 | 178 | 6 | ctd:C547185 | |
| Drug | Cinnarizine | 3.81e-05 | 9 | 178 | 3 | DB00568 | |
| Drug | SC68376 | 3.81e-05 | 9 | 178 | 3 | CID000005174 | |
| Drug | VX-745 | 4.02e-05 | 25 | 178 | 4 | CID003038525 | |
| Drug | Paclitaxel | COL6A3 VIT CDC14B GSN CCNB1 LIG1 FBN1 MAPK14 DST CSF3 MTOR VCAN CHFR KCNMA1 CTBP1 C4A MAPK13 | 5.30e-05 | 720 | 178 | 17 | ctd:D017239 |
| Drug | AC1NOLIT | 5.42e-05 | 10 | 178 | 3 | CID005090286 | |
| Drug | 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea | 6.08e-05 | 2 | 178 | 2 | DB06882 | |
| Drug | oridonin | 6.40e-05 | 54 | 178 | 5 | CID000034378 | |
| Drug | Mibefradil | 7.40e-05 | 11 | 178 | 3 | DB01388 | |
| Drug | EBNs | 7.40e-05 | 11 | 178 | 3 | CID000150695 | |
| Drug | arachidonoylglycine | 7.40e-05 | 11 | 178 | 3 | CID000004345 | |
| Drug | peonidin-3-glucoside | 7.40e-05 | 11 | 178 | 3 | CID000443654 | |
| Drug | nemorosone | 7.40e-05 | 11 | 178 | 3 | CID000637105 | |
| Drug | L001226 | 8.44e-05 | 30 | 178 | 4 | CID004373102 | |
| Drug | Antimycin A | 8.58e-05 | 92 | 178 | 6 | ctd:D000968 | |
| Drug | CGP57380 | 9.64e-05 | 31 | 178 | 4 | CID011644425 | |
| Drug | themisone | 9.81e-05 | 12 | 178 | 3 | CID000016235 | |
| Drug | sesamolin | 9.81e-05 | 12 | 178 | 3 | CID000101746 | |
| Drug | AC1L2VU3 | 9.81e-05 | 12 | 178 | 3 | CID000129572 | |
| Drug | Syk inhibitor | 9.82e-05 | 59 | 178 | 5 | CID006419747 | |
| Drug | Dasatinib | KNTC1 MCM8 NSD2 SRC MAP3K20 SVEP1 ARHGAP22 MAPK14 MTOR ALDH1L2 JAG1 ASNS CLSPN | 1.04e-04 | 478 | 178 | 13 | ctd:D000069439 |
| Drug | Ro 31 | 1.24e-04 | 141 | 178 | 7 | CID000214797 | |
| Drug | Mibefradil | 1.27e-04 | 13 | 178 | 3 | ctd:D020748 | |
| Drug | tetralol | 1.27e-04 | 13 | 178 | 3 | CID000010747 | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.39e-04 | 192 | 178 | 8 | 1517_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.44e-04 | 193 | 178 | 8 | 3908_DN | |
| Drug | CGX 0596987; Up 200; 20uM; PC3; HT_HG-U133A | 1.55e-04 | 195 | 178 | 8 | 6417_UP | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; HL60; HT_HG-U133A | 1.60e-04 | 196 | 178 | 8 | 2488_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.60e-04 | 196 | 178 | 8 | 3314_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A | 1.60e-04 | 196 | 178 | 8 | 2388_DN | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.60e-04 | 196 | 178 | 8 | 5827_DN | |
| Drug | SB-242235 | 1.61e-04 | 14 | 178 | 3 | CID009863367 | |
| Drug | SB202474 | 1.61e-04 | 14 | 178 | 3 | CID000005162 | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.66e-04 | 197 | 178 | 8 | 3925_UP | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 1.66e-04 | 197 | 178 | 8 | 6585_UP | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 1.66e-04 | 197 | 178 | 8 | 6801_UP | |
| Drug | Iopromide [73334-07-3]; Down 200; 5uM; PC3; HT_HG-U133A | 1.66e-04 | 197 | 178 | 8 | 4504_DN | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.72e-04 | 198 | 178 | 8 | 7178_DN | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; PC3; HT_HG-U133A | 1.72e-04 | 198 | 178 | 8 | 4071_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 198 | 178 | 8 | 4370_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.72e-04 | 198 | 178 | 8 | 6505_DN | |
| Drug | Sistan | 1.75e-04 | 36 | 178 | 4 | CID003001858 | |
| Drug | AC1L1KQK | 1.75e-04 | 36 | 178 | 4 | CID000005612 | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 178 | 8 | 6221_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; HL60; HT_HG-U133A | 1.78e-04 | 199 | 178 | 8 | 2990_UP | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Up 200; 8.8uM; HL60; HT_HG-U133A | 1.78e-04 | 199 | 178 | 8 | 3096_UP | |
| Drug | 2-aminothiophenol | 1.81e-04 | 3 | 178 | 2 | ctd:C005464 | |
| Drug | SureCN2398996 | 1.81e-04 | 3 | 178 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 1.81e-04 | 3 | 178 | 2 | CID000092154 | |
| Drug | 4-hydroxy-2-nonenal | SRC MAP3K20 ETS1 APC GSN CCNB1 CASK ARHGAP22 ARHGAP5 RSAD2 MAPK14 DST TBC1D31 CSF3 MTOR RAD54L GOT2 | 1.83e-04 | 798 | 178 | 17 | ctd:C027576 |
| Disease | Malignant neoplasm of breast | SYT3 TCP1 NSD2 APC2 SRC TECTA FAAH GSN TRMT2A AKAP9 CSF3 MTOR AFP JAG1 SYNE2 MACF1 CLSPN MAP2K7 TNS1 RAD54L | 5.44e-06 | 1074 | 173 | 20 | C0006142 |
| Disease | familial adenomatous polyposis 1 (implicated_via_orthology) | 3.42e-05 | 2 | 173 | 2 | DOID:0080409 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (is_implicated_in) | 5.42e-05 | 69 | 173 | 5 | DOID:4450 (is_implicated_in) | |
| Disease | colon cancer (is_implicated_in) | 5.81e-05 | 36 | 173 | 4 | DOID:219 (is_implicated_in) | |
| Disease | dementia, Parkinson disease, disease progression measurement | 1.02e-04 | 3 | 173 | 2 | EFO_0008336, MONDO_0001627, MONDO_0005180 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.12e-04 | 128 | 173 | 6 | DOID:4450 (is_marker_for) | |
| Disease | Feeding difficulties | 1.51e-04 | 18 | 173 | 3 | C0232466 | |
| Disease | cancer (implicated_via_orthology) | 1.94e-04 | 268 | 173 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of liver | 1.97e-04 | 142 | 173 | 6 | C0345904 | |
| Disease | Liver neoplasms | 1.97e-04 | 142 | 173 | 6 | C0023903 | |
| Disease | Obesity | 2.17e-04 | 205 | 173 | 7 | C0028754 | |
| Disease | Colorectal Carcinoma | DNAH3 DSTN MTHFD1L APC2 SRC APC LIG1 FBLN2 AKAP9 SACS ATP11C CTBP1 VWA2 | 2.72e-04 | 702 | 173 | 13 | C0009402 |
| Disease | severe acute respiratory syndrome, COVID-19 | COL6A3 THSD7A MTHFD1L NTRK2 BBS9 LRP1B CASK KCNMA1 CTBP2 EIF2AK1 | 3.26e-04 | 447 | 173 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | Intellectual Disability | 3.26e-04 | 447 | 173 | 10 | C3714756 | |
| Disease | mean platelet volume | TNPO1 GNPDA1 TTC28 POLR2A EML6 LCP1 SVEP1 ANKRD46 ADH4 RIMKLB UCP2 SYNE2 RIPOR1 LTBP1 ARAP1 TGS1 | 3.51e-04 | 1020 | 173 | 16 | EFO_0004584 |
| Disease | urate measurement, spine bone mineral density | 3.78e-04 | 58 | 173 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | household income | 4.51e-04 | 304 | 173 | 8 | EFO_0009695 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 4.66e-04 | 26 | 173 | 3 | DOID:234 (is_implicated_in) | |
| Disease | 4p partial monosomy syndrome | 5.05e-04 | 6 | 173 | 2 | cv:C1956097 | |
| Disease | colipase measurement | 5.05e-04 | 6 | 173 | 2 | EFO_0801485 | |
| Disease | WOLF-HIRSCHHORN SYNDROME | 5.05e-04 | 6 | 173 | 2 | 194190 | |
| Disease | insulin-like growth factor-binding protein 7 measurement | 5.05e-04 | 6 | 173 | 2 | EFO_0008161 | |
| Disease | thoracic aortic aneurysm, Abdominal Aortic Aneurysm, brain aneurysm | 5.05e-04 | 6 | 173 | 2 | EFO_0003870, EFO_0004214, EFO_0004282 | |
| Disease | prostate cancer (is_implicated_in) | 6.45e-04 | 117 | 173 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | Liver Cirrhosis, Experimental | GNPDA1 LCP1 GSN ADH4 KANK1 FBN1 CSF3 AFM ALDH1L2 AFP ASNS LTBP1 ABCG5 | 6.79e-04 | 774 | 173 | 13 | C0023893 |
| Disease | colorectal cancer (implicated_via_orthology) | 7.16e-04 | 30 | 173 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | 8.89e-04 | 509 | 173 | 10 | EFO_0004695 | |
| Disease | Pitt-Rogers-Danks Syndrome | 9.35e-04 | 8 | 173 | 2 | C0796117 | |
| Disease | hemoglobin A1 measurement | LINC00299 GSN DCUN1D1 JAG1 SYNE2 CHFR MACF1 ATP2B4 ARAP1 SMG6 | 1.04e-03 | 520 | 173 | 10 | EFO_0007629 |
| Disease | endometrial cancer (is_marker_for) | 1.13e-03 | 35 | 173 | 3 | DOID:1380 (is_marker_for) | |
| Disease | Wolf-Hirschhorn Syndrome | 1.20e-03 | 9 | 173 | 2 | C1956097 | |
| Disease | afamin measurement | 1.20e-03 | 9 | 173 | 2 | EFO_0008015 | |
| Disease | corneal resistance factor | 1.44e-03 | 451 | 173 | 9 | EFO_0010067 | |
| Disease | Bladder Neoplasm | 1.44e-03 | 140 | 173 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.49e-03 | 141 | 173 | 5 | C0005684 | |
| Disease | cataract | 1.49e-03 | 141 | 173 | 5 | MONDO_0005129 | |
| Disease | Marfan syndrome (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | Abnormality of nervous system morphology | 1.49e-03 | 10 | 173 | 2 | C4022810 | |
| Disease | squamous cell carcinoma, esophageal carcinoma | 1.49e-03 | 10 | 173 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | Drug toxicity | 1.53e-03 | 84 | 173 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 1.53e-03 | 84 | 173 | 4 | C0041755 | |
| Disease | asthma | LRRC3C COL6A3 GNPDA1 CDHR3 ETS1 LINC00299 LRP1B ANKRD46 FBLN2 CSF3 USP32 OSTF1 | 1.66e-03 | 751 | 173 | 12 | MONDO_0004979 |
| Disease | Mesothelioma | 1.79e-03 | 41 | 173 | 3 | C0025500 | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 1.82e-03 | 11 | 173 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 2.20e-03 | 44 | 173 | 3 | C0340427 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 2.55e-03 | 13 | 173 | 2 | OBA_2045174 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.55e-03 | 13 | 173 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Cardiomyopathy | 2.66e-03 | 47 | 173 | 3 | cv:C0878544 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | GAPVD1 TTC28 MAP3K20 LINC00299 MAPK14 SGSM2 ASNS CHFR HELZ CTBP1 MAPK13 SMG6 | 2.81e-03 | 801 | 173 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | pulse pressure measurement, social deprivation | 2.97e-03 | 14 | 173 | 2 | EFO_0005763, EFO_0009696 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 2.97e-03 | 14 | 173 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.99e-03 | 49 | 173 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Weight Gain | 3.10e-03 | 102 | 173 | 4 | C0043094 | |
| Disease | Generalized hypotonia | 3.41e-03 | 15 | 173 | 2 | C1858120 | |
| Disease | employment status | 3.41e-03 | 15 | 173 | 2 | EFO_0005241 | |
| Disease | pulse pressure measurement | COL6A3 TTC28 ANKRD36C LCP1 CASZ1 SVEP1 GSN FCSK TRIM66 JUP FBN1 JAG1 ULK4 LTBP1 TRIM49B VCL SMG6 | 3.48e-03 | 1392 | 173 | 17 | EFO_0005763 |
| Disease | reticulocyte count | EML6 LINC00299 LCP1 ANKRD46 DCUN1D1 RIMKLB JAG1 SYNE2 USP32 C4B EIF2AK1 TNS1 ATP2B4 SMG6 | 3.53e-03 | 1045 | 173 | 14 | EFO_0007986 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.74e-03 | 53 | 173 | 3 | C4707243 | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 3.89e-03 | 16 | 173 | 2 | EFO_0008297 | |
| Disease | Blood Platelet Disorders | 3.89e-03 | 16 | 173 | 2 | C0005818 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 3.89e-03 | 16 | 173 | 2 | C0334634 | |
| Disease | body mass index, type 2 diabetes mellitus | 3.89e-03 | 16 | 173 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | serum metabolite measurement | TNPO1 NTRK2 PTDSS1 LCP1 FAAH ADH4 PARP4 ALDH1L2 SYNE2 CHFR TRIM49B RIC1 GOT2 | 3.92e-03 | 945 | 173 | 13 | EFO_0005653 |
| Disease | Mammary Carcinoma, Human | 3.96e-03 | 525 | 173 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.96e-03 | 525 | 173 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 4.06e-03 | 527 | 173 | 9 | C1458155 | |
| Disease | alcohol dependence measurement | 4.16e-03 | 55 | 173 | 3 | EFO_0007835 | |
| Disease | Benign neoplasm of stomach | 4.39e-03 | 17 | 173 | 2 | C0153943 | |
| Disease | response to radiation, Urinary retention | 4.39e-03 | 17 | 173 | 2 | GO_0009314, HP_0000016 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 4.39e-03 | 17 | 173 | 2 | C2936862 | |
| Disease | Eye Abnormalities | 4.39e-03 | 17 | 173 | 2 | C0015393 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.39e-03 | 17 | 173 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 4.39e-03 | 17 | 173 | 2 | C0154060 | |
| Disease | Breast Carcinoma | 4.64e-03 | 538 | 173 | 9 | C0678222 | |
| Disease | body surface area | 4.82e-03 | 643 | 173 | 10 | EFO_0022196 | |
| Disease | progression free survival, ovarian carcinoma | 4.92e-03 | 18 | 173 | 2 | EFO_0001075, EFO_0004920 | |
| Disease | Bardet-Biedl syndrome | 4.92e-03 | 18 | 173 | 2 | cv:C0752166 | |
| Disease | Alcoholic Intoxication, Chronic | 5.13e-03 | 268 | 173 | 6 | C0001973 | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 5.47e-03 | 19 | 173 | 2 | EFO_0007709 | |
| Disease | open-angle glaucoma | 5.48e-03 | 191 | 173 | 5 | EFO_0004190 | |
| Disease | serum non-albumin protein measurement | 5.59e-03 | 361 | 173 | 7 | EFO_0004568 | |
| Disease | colorectal cancer (is_implicated_in) | 5.70e-03 | 121 | 173 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Varicose veins | 5.72e-03 | 193 | 173 | 5 | HP_0002619 | |
| Disease | mean corpuscular hemoglobin concentration | TNPO1 KNTC1 TTC28 POLR2A POT1 LINC00299 LCP1 UBR5 BBS7 MACF1 CACNA1I CLSPN MAP2K7 ATP2B4 | 5.73e-03 | 1105 | 173 | 14 | EFO_0004528 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KARDNFEGGCLAELI | 6 | Q6ZSB3 | |
| EDGFLAVCSEAKGLV | 151 | P08243 | |
| EALCGQEEPLLAFKG | 1136 | Q86US8 | |
| ILCIDSFDIVGDGVK | 241 | Q8IWZ6 | |
| LGGFQECEDATLALL | 3726 | Q99996 | |
| DIKSAGDLGIAVCNV | 106 | Q13363 | |
| VDIKAAGELGIAVCN | 111 | P56545 | |
| EAAQKACLDVGAVIA | 166 | P13611 | |
| LEGGKGDQADLDVNC | 546 | O95196 | |
| DVQAGACEGKLELSV | 561 | P0C0L5 | |
| QSGEADVILECLGFK | 76 | Q32M84 | |
| IELTKGGVDFALDCA | 261 | P08319 | |
| CFEAIGNLDVLAAAL | 266 | P28332 | |
| EECGALFSTLDGAIK | 1036 | Q86V15 | |
| VDNLADLVFGELCGV | 471 | P43652 | |
| VKEFLDICENAEGAI | 296 | O60729 | |
| EEILGFGKSVCDSLG | 351 | Q8NEB7 | |
| GGKSPLIIFNDCELD | 696 | Q3SY69 | |
| ACIADFGLALKFEAG | 336 | P27037 | |
| DDKCANLFEALVGTL | 36 | Q9P1F3 | |
| QAELALKSEGFCDID | 251 | Q9Y2F9 | |
| DFLIKAGADIELGCS | 551 | O75179 | |
| GNVDICQLLHKFGAD | 56 | Q86W74 | |
| EDLNRACIAEKLGGS | 141 | P60981 | |
| DLVCELAKRAGAFDA | 811 | Q6UB35 | |
| IGIDGIQQFCDDLAL | 81 | Q96GG9 | |
| CLAVGGLDVKSQEAA | 321 | Q96GQ7 | |
| LDNFLGEVVGDCVLE | 31 | Q9H6Z9 | |
| VVIDLGEAFTKCGFA | 16 | Q9NZ32 | |
| GDDFLCLEGKEFNRL | 716 | P23634 | |
| LLKAGCDLDVQDDGD | 61 | Q9Y2G4 | |
| DLDFTIDLDFKGQLC | 346 | Q99873 | |
| QGELKRAICGFDALA | 1016 | Q5JR59 | |
| KCVEEEDGFVGALDL | 466 | Q92698 | |
| LKDLGCFAAQLGFEL | 1076 | Q4ADV7 | |
| QVAFDGFILCKEGED | 146 | Q8N149 | |
| VGQEFLLLAGEEELC | 196 | A6NJW4 | |
| LNFGCLDDIGHGIKD | 141 | Q9P2A4 | |
| LGAEAVGLVKECNDN | 81 | Q9NW15 | |
| DAACGIDKTENGTLF | 476 | Q5JPF3 | |
| GADLCFEIVKRADAG | 96 | O14936 | |
| LDGKVISFEGCAVQL | 101 | Q8NGN2 | |
| GFQLKDDGKTCVDID | 2956 | Q9NZR2 | |
| DDAICLAELKLGFIA | 546 | Q12791 | |
| CLLENGFSGNVKVDE | 201 | O60524 | |
| ALVLGDQGICGIDEF | 506 | Q9UJA3 | |
| AECDAFEEKIKAAGG | 116 | P46926 | |
| LAVNEDCELKILDFG | 156 | Q16539 | |
| IKFCLDPAEGENSIA | 4981 | Q03001 | |
| KFCGIINISVEGLHD | 866 | Q9UI26 | |
| DKSCVAAFLDVVIGG | 371 | Q14C86 | |
| FEFIEEAHQCGKGLL | 391 | Q9Y6W6 | |
| NGAALCALGKDCFLE | 101 | P14921 | |
| GFLLAADGKRCEDVN | 931 | P98095 | |
| NDLFNAVGDGIVLCK | 151 | P13796 | |
| DECLLFGQEICKNGF | 1426 | Q14766 | |
| LDERGQIKLCDFGIS | 251 | O14733 | |
| LVAFEGEGQFEKLCQ | 281 | O96028 | |
| IVEELFGCGDVNAKA | 1216 | Q14678 | |
| KGLLACGADVNIQDD | 1251 | Q14678 | |
| LQGERGALDAELKAC | 176 | Q8N1N4 | |
| LAVNEDCELKILDFG | 156 | O15264 | |
| EVDVVGLCQEGKFLL | 86 | P50748 | |
| GIKDGEAFNVALCEL | 321 | Q6ZNW5 | |
| LLAKGACVLAVDENA | 961 | Q8N8A2 | |
| LIDLCDGQADQAAKV | 821 | Q9NZB2 | |
| LDDKAAVCGFEAFIN | 661 | Q9UKK3 | |
| LIAICGEEGLFSKNQ | 1236 | Q6IE36 | |
| LSGLDVSFCDKVGDQ | 281 | Q8N1E6 | |
| EGLAKGEDAFRAVLC | 86 | P42694 | |
| GVLCELAQDKEAADA | 606 | P14923 | |
| STILGDKEEFDQGCL | 11 | Q3SYG4 | |
| ILGADLIFACGETEK | 6066 | Q9UPN3 | |
| KGNDFEVPDCFLEIA | 531 | Q3B8N5 | |
| FLEQGDGEKIAVLQC | 466 | Q4G163 | |
| PQLEDCLGIGAAFEK | 211 | Q6GPH6 | |
| LECGDLAAGVEALAQ | 641 | Q8N0W3 | |
| ENKAAICQVDGALGF | 566 | O95996 | |
| FCELNLGDKCLDGVL | 536 | Q96EP1 | |
| AGAFCLALKILDNGE | 346 | P14635 | |
| ELENKAAVPLGGFLC | 656 | Q7L8L6 | |
| IFAALGVELFGDLEC | 1756 | O43497 | |
| LQLGAKVDFVCDEGF | 376 | P17927 | |
| LQLGAKVDFVCDEGF | 826 | P17927 | |
| LQLGAKVSFVCDEGF | 1276 | P17927 | |
| AAIAQGIKNECEGDL | 2746 | Q8TD57 | |
| QVKIGDFGLACTDIL | 456 | Q9BQI3 | |
| EGDCDFQLLKLDGKF | 111 | P02765 | |
| CNKGFQLDLRGECID | 476 | P35555 | |
| GTLLLDLNKFCFDDD | 361 | Q6ZTQ4 | |
| LGVELFGKLVCNDEN | 1636 | Q9P0X4 | |
| AAKACNLDVILGFDG | 1831 | P12111 | |
| DKIAILSFGELIFCG | 261 | Q9H222 | |
| IAADGVLKICDFGAS | 141 | Q9NYL2 | |
| AECDAFENKIKEAGG | 116 | Q8TDQ7 | |
| GDGAALQEKLVSECA | 56 | P09919 | |
| IADDKLFLCGGLSAD | 256 | Q8N7A1 | |
| FAQGALKSEDCFILD | 321 | P06396 | |
| SADGKCLVSVGLDDF | 781 | Q6ZMW3 | |
| NFKGDFVDPCLGDLV | 391 | O00519 | |
| LDAIAKEGCSGLLEE | 531 | O60645 | |
| KEGCSGLLEEVFLDL | 536 | O60645 | |
| LGVELFGRLECSEDN | 1766 | O95180 | |
| DSEELQAICKLGTGF | 786 | P18858 | |
| QAICKLGTGFSDEEL | 791 | P18858 | |
| QFVPAVEKGFLDACE | 581 | Q96RP9 | |
| VGKGCDNNFIEDVLG | 1171 | O95487 | |
| GFEEAGCKQILLENT | 2036 | Q9NZJ4 | |
| GCLAAELLALDEKDN | 971 | Q56UN5 | |
| DVQAGACEGKLELSV | 561 | P0C0L4 | |
| EDKLLACGEGAADII | 466 | P02771 | |
| DSQVAFDGFILCKEG | 146 | Q8N6C8 | |
| EGVLDVKASNLLDCG | 1066 | Q5THK1 | |
| ECLDNRVGVNGLDKA | 91 | Q92882 | |
| LDCADALLKAGADVN | 61 | Q9Y283 | |
| AKVCGASGQFELEIL | 26 | P78504 | |
| ICDGDAANDLTLKDG | 2251 | Q6ZRI0 | |
| DDNGIVLLGERAAKC | 1376 | P42345 | |
| GDDLSRVNKEACLAG | 136 | P53609 | |
| GSEKADLGELNFSLC | 426 | Q9BQG1 | |
| LVGENLVCKVADFGL | 396 | P12931 | |
| NKCEFLVGVGVDGED | 241 | Q8IZ69 | |
| AIFSEELDGLCFKGE | 251 | Q494U1 | |
| CKLLFEIGSLDEGIS | 296 | Q96DN5 | |
| GLNVIDANLCVKGED | 156 | Q8WXA3 | |
| EFCADIELIIDGNKN | 1386 | Q9UPZ6 | |
| KVFQCLLIEGENCGE | 246 | Q8WXG1 | |
| AFLLETCKDQGLGDN | 4291 | Q8WXH0 | |
| EVLFGVLDFAGCTKN | 331 | Q15573 | |
| LFCDGGDVKFVLDSA | 111 | A6NEY8 | |
| CQLLGKAEVDGASFL | 166 | Q9NUX5 | |
| GELEAGEELAAVCAA | 766 | O43147 | |
| CLEEQGLKFVGQDVE | 491 | P17812 | |
| CELADLQDKEVGDGT | 76 | P17987 | |
| EGKLNVDGFLLCIDV | 151 | Q13017 | |
| VLVDDGLACKVADFG | 356 | Q9H3Y6 | |
| LNNGVCKDLVGEFIC | 1241 | Q4LDE5 | |
| FKLLGLSEITCEADG | 3036 | Q4LDE5 | |
| LFCGDTVEILEGKDA | 56 | Q96A35 | |
| LACLSEEGNEIESGK | 211 | Q9Y2L1 | |
| FLSCAQLLTKDEGEG | 251 | Q7Z5H3 | |
| ICVKLDLTGGAFEDN | 331 | Q67FW5 | |
| GLAEFCKASAELALG | 101 | P00505 | |
| FGNQEELDKALCAAV | 656 | Q96P48 | |
| ADFLIKAGADIELGC | 521 | Q8IWZ3 | |
| ENKADICAVDGALAF | 601 | P25054 | |
| GCLLVDKDLFETGLE | 206 | Q9HAW4 | |
| VIFHCNIKDLEFGGD | 61 | Q8N6V4 | |
| QGFLKEGCELINEAL | 991 | O75153 | |
| TQEGDILLFCKGADS | 556 | Q8NB49 | |
| NCLVGENLLVKIGDF | 681 | Q16620 | |
| FEEICNGECGDLLKA | 881 | O75443 | |
| KFLGAGTAACIADLI | 16 | P55851 | |
| AVLQEGDEGCKALIS | 276 | Q9C0A1 | |
| AVQGCVLQKLLFEGD | 461 | Q4G0A6 | |
| GGEKCVAALALLFAV | 1126 | Q8NDV3 | |
| CGLFELEEEDEQSKG | 496 | P38935 | |
| IDGEEGLFLLGCVKE | 371 | Q9BSJ1 | |
| IAEKINAGFGDDLNC | 1231 | P24928 | |
| CAIHDLGVVFGKEDL | 271 | Q9HBL0 | |
| QILDEAGKVGELCAG | 301 | P18206 | |
| FGGEANCALKLSLEC | 326 | Q5GFL6 | |
| GDPNCKIDLSFLIDG | 286 | Q6UXI7 | |
| AFDKACNLDVAGIIA | 286 | Q9ULI2 | |
| AFGALQKICEDSAEI | 156 | Q92973 | |
| SKEEAFDAICQLVAG | 91 | Q9BW30 | |
| TKEDLVQICGAADGI | 401 | Q9NZI7 | |
| GGLKLFLECLNNDTE | 506 | Q7Z3V4 | |
| ALGFDLCEVGQEEVI | 1901 | Q96AY4 | |
| HLKEAGFCIQEAAGL | 726 | Q9ULT0 | |
| SEDEVLVGNAALCLG | 616 | Q9H892 | |
| IDGEDGLFLLGCVKN | 371 | A6NDI0 | |
| GIADKIEFICGDFLL | 736 | Q96RS0 | |
| LEAIIATGCFGIDKE | 1746 | Q12789 | |
| KNDQDGSFLLIIECG | 886 | O15016 | |
| LAEAVCVKFLEDALG | 1011 | Q6ZS17 | |
| KAAFDIFVLGAEDGC | 21 | P63316 | |
| GDLLEFIKCQGALHE | 96 | Q96PF2 | |
| GFLEAIVCIKFGQDL | 361 | P48651 | |
| KLLLEADELCDDGGD | 256 | O15209 | |
| KENGAGQICELADAL | 1431 | Q8NFA0 | |
| AFAIDLCKEEGGGQV | 2601 | O95071 | |
| CLAKVEGENLEEFFA | 141 | Q96C45 | |
| VNEDCELKILDFGLA | 161 | P53778 |